Кератоконус

40.Szczotka L.B., Barr J.T., Zadnik K.A. A summary of the findings from the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. CLEK Study Group // Optometry.- 2001.- Vol.72,№9.- Р.574 - 584.

41.Tachibana M., Adachi W., Kinoshita S. et al. Androgen-dependent hereditary mouse keratoconus: linkage to an MHC region // Invest. Ophthalmol.- 2002.- Vol.43, №1.- Р.51 – 57.

42.Tyynismaa H., Sistonen P., Tuupanen S. et al. A locus for autosomal dominant keratoconus: linkage to 16q22.3 – q23.1 in Finnish families // Invest. Ophthalmol. Vis. Sci.- 2002.- Vol.43,№10.- Р.3160 – 3164.

43.Uiters E., Van den Borne B., Van den Horst F.G., Volker-Dieben H.J. Patient satisfaction after cornea transplantation // Cornea.- 2001.- Vol.20,№7.- Р.687 – 694.

44.Weiss J. Enzymic degradation of collagen // Intern. Rev. Connect. Tissue Res.- 1976.- Vol.7,№2.- Р.101 – 157.

45.Wentz-Hunter K., Cheng E.L., Ueda J. et al. Keratokan expression is increased in the stroma of keratoconus corneas // Mol. Med.- 2001.- Vol.7,№7.- Р.470 – 477.

46.Wilson S.E., Kim W.J., Mohan R.R., Meisler D.M. Keratocyte apoptosis and keratoconus // 13th Inter. Ophthalmol. Congress.- 26 –31 Jul.- Paris,1998.

47.Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus // Am. J. Ophthalmol.- 2003.- Vol.135, №5- Р.620-627.

48.Woodward E.G. Keratoconus - Epidemiology // J.B.C.L.A.- 1984.- Vol.7.- P.64 -

49.Zadnik K., Barr J.T., Gordon M.O., Edrington T.B. Biomicroscopic signs and disease severity in keratoconus // Cornea.- 1996.- Vol.15,№2.- Р.139 - 146.

50.Zhou L., Sawaguchi S., Twining S.S. et al. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus // Invest. Ophthalmol. Vis. Sci.- 1998.- Vol.39,№7.- Р.1117 – 1124.

18